SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Neptune Technologies & Bioressources Inc. - NTB.V
An SI Board Since July 2011
Posts SubjectMarks Bans Symbol
902 9 0 NEPT
Emcee:  Sultan Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
677Neptune Reports Fiscal 2020 First Quarter Results finance.yahoo.comSultan-8/14/2019
676Acasti Pharma Provides Business Update for the First Quarter of Fiscal 2020 acaSultan-8/14/2019
675Acasti Pharma Co-Founder, Chief Operating and Scientific Officer to Participate Sultan-8/9/2019
674He Was Expected To Fail Because Of His Dyslexia. He Then Made His First $1 MilliSultan-8/7/2019
673CEO on BNN Bloomberg bnnbloomberg.caSultan-8/2/2019
672Rise of Neptune cheddar.comSultan-7/29/2019
671Neptune to Hold Conference Call to Discuss First Quarter Results Ended June 30, Sultan-7/29/2019
670ACASTI PHARMACEUTICALS UPDATE – MARKET FINALLY WAKES UP TO THE POTENTIAL IMPLICASultan17/28/2019
669Neptune Wellness gets “Top Pick” status at Echelon Wealth Partners cantechletteSultan-7/26/2019
668Acasti Pharma Comments on Trading Activity and Reaffirms No Plans to Raise CapitSultan-7/25/2019
667Neptune Closes SugarLeaf Acquisition, Expanding U.S. Extraction Capabilities fiSultan-7/24/2019
666Acasti sits pretty as raise brings $400M for Amarin bioworld.comSultan17/19/2019
665Form 13G for ACST Schedule filed to report acquisition of beneficial ownershipSultan-7/19/2019
664Neptune Wellness Solutions Closes US$41 Million Private Placement finance.yahooSultan-7/18/2019
663Oppenheimer initiated Acasti Pharma (ACST) coverage with Outperform rating and pSultan-7/18/2019
662Insider Trades Pretty rich payout to new CEO.. 2,800,000 restricted share unSultan-7/15/2019
661Introducing The New NYSE Pure-Play Cannabis ETF thecannabisinvestor.caSultan-7/13/2019
660Two prominent research firms initiate coverage on Acasti Pharma with Buy rating Sultan-7/13/2019
659Aegis Capital analyst Nathan Weinstein initiates coverage on Acasti Pharma (NASDSultan-7/9/2019
658Neptune Appoints Schmidt’s Naturals Co-Founder Michael Cammarata CEO As CPG ExecSultan-7/9/2019
657Neptune Appoints Michael Cammarata as Chief Executive Officer finance.yahoo.comSultan-7/8/2019
656Acasti Pharma, Inc. (ACST) CEO Jan D'Alvise on Q4 2019 Results - Earnings CaSultan-6/26/2019
655Acasti Pharma Provides Fiscal 2019 Year-End Business Update acastipharma.comSultan-6/26/2019
654Home-Run Hitters, At Bat With Acasti Pharma seekingalpha.comSultan16/25/2019
653 Neptune Wellness Solutions Inc forms bullish "Continuation Diamond" cSultan16/25/2019
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News